Epigral Limited (NSE:EPIGRAL)

India · Delayed Price · Currency is INR

1,108.90

+3.60 (0.33%)

Sep 21, 2026, 9:40 AM IST

Market Cap	47.68B -38.3%
Revenue (ttm)	26.26B +4.8%
Net Income	2.71B -37.3%
EPS	62.82 -38.1%
Shares Out	43.14M
PE Ratio	17.59
Forward PE	13.76
Dividend	5.00 (0.45%)
Ex-Dividend Date	Jun 1, 2026

Volume	25,027
Open	1,109.80
Previous Close	1,105.30
Day's Range	1,101.70 - 1,112.30
52-Week Range	807.00 - 1,808.80
Beta	0.21
Analysts	Strong Buy
Price Target	1,728.00 (+55.83%)
Earnings Date	Oct 27, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharm... [Read more]

Industry Chemicals

Sector Materials

Founded 2007

Employees 1,135

Stock Exchange National Stock Exchange of India

Ticker Symbol EPIGRAL

Full Company Profile

Financial Performance

In fiscal year 2026, Epigral's revenue was 25.27 billion, a decrease of -0.90% compared to the previous year's 25.50 billion. Earnings were 3.32 billion, a decrease of -7.19%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for EPIGRAL stock is "Strong Buy." The 12-month stock price target is ₹1,728, which is an increase of 55.83% from the latest price.

Price Target

₹1,728

(55.83% upside)

Analyst Consensus: Strong Buy

Stock Forecasts